Pfizer, AstraZeneca notify CADE of allopathic medicine deal for fast-track review
MLex Summary: Pharmaceutical giant Pfizer and biopharmaceutical company AstraZeneca have notified the Brazilian competition authority of a deal under which the companies intend to develop and market allopathic medicines in Brazil. The deal is awaiting...To view the full article, register now.
Already a subscriber? Click here to view full article